Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 08, 2023, titled "Eugia Pharma receives USFDA Approval for Lenalidomide Capsules".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 08, 2023, titled "Eugia Pharma receives USFDA Approval for Lenalidomide Capsules".